Cargando…

Breast cancer screening in the Czech Republic: time trends in performance indicators during the first seven years of the organised programme

BACKGROUND: The Czech Breast Cancer Screening Programme (CBCSP) was initiated in September 2002 by establishing a network of accredited centres. The aim of this article is to describe progress in the programme quality over time after the inception of the organised programme. METHODS: The CBCSP is mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Majek, Ondrej, Danes, Jan, Skovajsova, Miroslava, Bartonkova, Helena, Buresova, Lucie, Klimes, Daniel, Brabec, Petr, Kozeny, Pavel, Dusek, Ladislav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112123/
https://www.ncbi.nlm.nih.gov/pubmed/21554747
http://dx.doi.org/10.1186/1471-2458-11-288
_version_ 1782205702966607872
author Majek, Ondrej
Danes, Jan
Skovajsova, Miroslava
Bartonkova, Helena
Buresova, Lucie
Klimes, Daniel
Brabec, Petr
Kozeny, Pavel
Dusek, Ladislav
author_facet Majek, Ondrej
Danes, Jan
Skovajsova, Miroslava
Bartonkova, Helena
Buresova, Lucie
Klimes, Daniel
Brabec, Petr
Kozeny, Pavel
Dusek, Ladislav
author_sort Majek, Ondrej
collection PubMed
description BACKGROUND: The Czech Breast Cancer Screening Programme (CBCSP) was initiated in September 2002 by establishing a network of accredited centres. The aim of this article is to describe progress in the programme quality over time after the inception of the organised programme. METHODS: The CBCSP is monitored using an information system consisting of three principal components: 1) the national cancer registry, 2) a screening registry collecting data on all screening examinations, further assessments and final diagnoses at accredited programme centres, and 3) administrative databases of healthcare payers. Key performance indicators from the European Guidelines have been adopted for continuous monitoring. RESULTS: Breast cancer incidence in the Czech Republic has steadily been increasing, however with a growing proportion of less advanced stages. The mortality rate has recently stabilised. The screening registry includes 2,083,285 records on screening episodes between 2002 and 2008. In 2007-2008, 51% of eligible women aged 45-69 were screened. In 2008, the detection rates were 6.1 and 3.7 per 1,000 women in initial and subsequent screening respectively. Corresponding recall rates are 3.9% and 2.2%, however, it is necessary to pay attention to further assessment performed during the screening visits. Benign to malignant open biopsy ratio was 0.1. Of invasive cases detected in screening, 35.6% was less than 10 mm in diameter. Values of early performance indicators, as measured by both crude and standardized estimates, are generally improving and fulfil desirable targets set by European Guidelines. CONCLUSIONS: Mammography screening in the Czech Republic underwent successful transformation from opportunistic prevention to an organised programme. Values of early indicators confirm continuous improvement in different aspects of process quality. Further stimulation of participation through invitation system is necessary to exploit the full potential of screening mammography at the population level.
format Online
Article
Text
id pubmed-3112123
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31121232011-06-11 Breast cancer screening in the Czech Republic: time trends in performance indicators during the first seven years of the organised programme Majek, Ondrej Danes, Jan Skovajsova, Miroslava Bartonkova, Helena Buresova, Lucie Klimes, Daniel Brabec, Petr Kozeny, Pavel Dusek, Ladislav BMC Public Health Research Article BACKGROUND: The Czech Breast Cancer Screening Programme (CBCSP) was initiated in September 2002 by establishing a network of accredited centres. The aim of this article is to describe progress in the programme quality over time after the inception of the organised programme. METHODS: The CBCSP is monitored using an information system consisting of three principal components: 1) the national cancer registry, 2) a screening registry collecting data on all screening examinations, further assessments and final diagnoses at accredited programme centres, and 3) administrative databases of healthcare payers. Key performance indicators from the European Guidelines have been adopted for continuous monitoring. RESULTS: Breast cancer incidence in the Czech Republic has steadily been increasing, however with a growing proportion of less advanced stages. The mortality rate has recently stabilised. The screening registry includes 2,083,285 records on screening episodes between 2002 and 2008. In 2007-2008, 51% of eligible women aged 45-69 were screened. In 2008, the detection rates were 6.1 and 3.7 per 1,000 women in initial and subsequent screening respectively. Corresponding recall rates are 3.9% and 2.2%, however, it is necessary to pay attention to further assessment performed during the screening visits. Benign to malignant open biopsy ratio was 0.1. Of invasive cases detected in screening, 35.6% was less than 10 mm in diameter. Values of early performance indicators, as measured by both crude and standardized estimates, are generally improving and fulfil desirable targets set by European Guidelines. CONCLUSIONS: Mammography screening in the Czech Republic underwent successful transformation from opportunistic prevention to an organised programme. Values of early indicators confirm continuous improvement in different aspects of process quality. Further stimulation of participation through invitation system is necessary to exploit the full potential of screening mammography at the population level. BioMed Central 2011-05-10 /pmc/articles/PMC3112123/ /pubmed/21554747 http://dx.doi.org/10.1186/1471-2458-11-288 Text en Copyright ©2011 Majek et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Majek, Ondrej
Danes, Jan
Skovajsova, Miroslava
Bartonkova, Helena
Buresova, Lucie
Klimes, Daniel
Brabec, Petr
Kozeny, Pavel
Dusek, Ladislav
Breast cancer screening in the Czech Republic: time trends in performance indicators during the first seven years of the organised programme
title Breast cancer screening in the Czech Republic: time trends in performance indicators during the first seven years of the organised programme
title_full Breast cancer screening in the Czech Republic: time trends in performance indicators during the first seven years of the organised programme
title_fullStr Breast cancer screening in the Czech Republic: time trends in performance indicators during the first seven years of the organised programme
title_full_unstemmed Breast cancer screening in the Czech Republic: time trends in performance indicators during the first seven years of the organised programme
title_short Breast cancer screening in the Czech Republic: time trends in performance indicators during the first seven years of the organised programme
title_sort breast cancer screening in the czech republic: time trends in performance indicators during the first seven years of the organised programme
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112123/
https://www.ncbi.nlm.nih.gov/pubmed/21554747
http://dx.doi.org/10.1186/1471-2458-11-288
work_keys_str_mv AT majekondrej breastcancerscreeningintheczechrepublictimetrendsinperformanceindicatorsduringthefirstsevenyearsoftheorganisedprogramme
AT danesjan breastcancerscreeningintheczechrepublictimetrendsinperformanceindicatorsduringthefirstsevenyearsoftheorganisedprogramme
AT skovajsovamiroslava breastcancerscreeningintheczechrepublictimetrendsinperformanceindicatorsduringthefirstsevenyearsoftheorganisedprogramme
AT bartonkovahelena breastcancerscreeningintheczechrepublictimetrendsinperformanceindicatorsduringthefirstsevenyearsoftheorganisedprogramme
AT buresovalucie breastcancerscreeningintheczechrepublictimetrendsinperformanceindicatorsduringthefirstsevenyearsoftheorganisedprogramme
AT klimesdaniel breastcancerscreeningintheczechrepublictimetrendsinperformanceindicatorsduringthefirstsevenyearsoftheorganisedprogramme
AT brabecpetr breastcancerscreeningintheczechrepublictimetrendsinperformanceindicatorsduringthefirstsevenyearsoftheorganisedprogramme
AT kozenypavel breastcancerscreeningintheczechrepublictimetrendsinperformanceindicatorsduringthefirstsevenyearsoftheorganisedprogramme
AT dusekladislav breastcancerscreeningintheczechrepublictimetrendsinperformanceindicatorsduringthefirstsevenyearsoftheorganisedprogramme